GlassScriptPhysician profile
Nicholas Pappas
NPI 1376603969
$8,578.97
in general payments reported to CMS, 2019-2025
18 companies · $2,058 in 2025
The $2,058 reported for 2025 was more than what 83% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2021: $95.91 · 2023: $38.60 · 2024: $6,223 · 2025: $2,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Honoraria: $2,000 · Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Honoraria | $2,000.00 |
| Food and Beverage | $318.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biopro, INC. | $8,000.00 | 2024-2025 | Mod Thumb, Palingen |
| Janssen Pharmaceuticals, INC | $88.40 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $85.85 | 2019-2023 | Seglentis |
| Convatec INC. | $78.12 | 2024 | |
| Axogen | $54.08 | 2019 | |
| Endo USA, INC. | $38.08 | 2024-2025 | Xiaflex |
| Averitas Pharma INC. | $28.34 | 2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $26.18 | 2024 | Nuzyra |
| Ibsa Pharma INC. | $24.53 | 2023 | Tirosint, Licart |
| Zimmer Biomet Holdings, INC. | $24.33 | 2025 | Tapestry |
| Sonex Health, INC. | $19.84 | 2024 | Sx-One Microknife |
| Amarin Pharma, INC. | $19.44 | 2019 | |
| Bioventus LLC | $17.64 | 2024 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $16.18 | 2024 | Krystexxa |
| Organogenesis INC. | $15.94 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.42 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.40 | 2019 | |
| Horizon Therapeutics Plc | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Pappas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.